openPR Logo
Press release

Adult Vaccines Market, By Types of Vaccines (Monovalent and Multivalent) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

03-12-2018 03:58 PM CET | Health & Medicine

Press release from: CMI - Market Research

Adult Vaccines Market, By Types of Vaccines (Monovalent

Vaccination is one of the most effective and safest therapy that protects from diseases and reduces the prevalence of infectious diseases. There are rare side effects associated with vaccinations. Most of the vaccines are recommended on the basis of person’s age, lifestyle, travel destinations, and health conditions such as diabetes, heart diseases, asthma, and chronic obstructive pulmonary disease (COPD). According to Centers for Disease Control and Prevention (CDC), in 2013, around 226,000 people are hospitalized every year and between 3,000 and 49,000 people die due to influenza and its complications, with major population of adults. Moreover, around 900,000 people are infected by pneumococcal pneumonia every year, among which, around 400,000 people get hospitalized and 19,000 people die, and around one million cases of shingles occur annually. CDC estimated that financial burden of adult vaccine preventable diseases (VPD) in the U.S. at around US$ 10 billion annually. However, CDC recommends that adult must be vaccinated against various infections such as influenza, pertussis (whooping cough), chickenpox, diphtheria, measles, hepatitis A and B, meningococcal disease (meningitis), human papillomavirus, mumps, pneumococcal disease (pneumonia), rubella, shingles, and tetanus.

To get holistic SAMPLE with TOC @

Initiatives by state authorities against viral and bacterial infections and innovation of novel vaccines is expected to fuel growth of the market

In August 2017, GlaxoSmithKline and Ali health promoted HPV/Cervarix – which is a part of online shopping program named Taobao. It offer many features, which include pediatric and adult vaccine information and links of 1500 health clinics for consultations and appointments in China. This in turn, is expected to fuel growth of the adult vaccine market in the near future. Moreover, Dallas County Health and Human Services (DCHHS), in August 2017, is offering seasonal flu vaccine for adults. It provides all-in-one shot vaccine for multiple flu strains, including H1N1, after recommended by CDC for flu prevention. Thus, various initiatives by the health authority reduces flu impact in the U.S., which in turn, is expected to fuel growth of the adult vaccines market.

In 2016, Protein Science Corporation announced 2016/17 formulation of Flubok influenza vaccine approved by FDA for 18 years and above.

According to Public Health England (PHE), in September 2017, it was reported that vaccine shot given for influenza were ineffective in patients over 65 years of age, as it was inactivated form of vaccine. However, nasal influenza vaccine reduced risk of influenza in children. PHS suggest the development of new vaccines, which may provide better protection from infections in geriatric population. Thus, it provides an opportunity to key players operating in adult vaccine market to develop effective vaccines for geriatric population.

In 2017, World Health organization (WHO) published a list of candidate vaccines in development for seven pathogen areas such as HIV, malaria, tuberculosis, Shigella, Respiratory Syncytial Virus (RSV), Enterotoxigenic E. Coli (ETEC), and Norovirus. Development of new vaccines against range of severe infections, is expected to propel growth of the adult vaccine in the near future.

Increasing prevalence of viral or bacterial communicable and non-communicable infections in adults, fuels growth of the adult vaccine market

According to the Immunization Action Coalition (IAC), which is a member of the WHO-led project Vaccine Safety Net (VSN), an incidences took place, followed in 2017, around 166,000 cases of flu were reported in the U.S. and around 71 people died in September 2017. Moreover, in 2016, around 91,000 people were impacted from flu in last five years. Moreover, in Canada, Vancouver Coastal Health issued a warning to teens and young adults against mumps in 2017. As per IAC, February to August 2017 approximately 80 cases of mumps were reported. According to World Health Organization (WHO), in 2016, pregnant women and elder individual, aged 65 years and above, and health workers are always at higher risk of infections. Moreover, according to CDC, people traveling for vacations every year for business and volunteerism have higher risk for development of infections. Vaccination is made compulsory for travelers by state and local health departments, which in turn, is expected to fuel growth of the adult vaccines market.

Key players operating in the global adult vaccines market include GlaxoSmithKline, plc, Panacea Biotec, Pfizer, Inc., Protein Sciences Corporation, Merck & Co., Inc., Daiichi Sankyo, Sanofi Pasteur SA, Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Bavarian Nordic, CSL Limited, Serum Institute of India Pvt. Ltd., ), Emergent BioSolutions, Inc., MedImmune, LLC, and Johnson & Johnson.

Complete Report Details @

“Catch us at 3rd International Conference on Separation + Drying Technologies for Milk & Whey at Cologne, March 19 and 20, 2018”

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit our news Website:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adult Vaccines Market, By Types of Vaccines (Monovalent and Multivalent) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here

News-ID: 975277 • Views: 518

More Releases from CMI - Market Research

Optogenetics Market, By Sensors (pH Sensors, Genetically Modified Calcium Indica …
Optogenetics is an emerging medical technique, which involves the use of light to control cells in living tissues, especially neurons to help study the characteristics of normal and abnormal brain function. Optogenetics is an emerging field of biotechnology trending among the fields of neuroscience, cardiology, ophthalmology, behavioral science, and other healthcare domains. The technique is widely used to treat neurological disorders such as depression. Depression is caused by chronic stress
X-ray Equipment Market, By Product Type (Computed Tomography, Mobile X-Ray Devic …
X-ray equipment in healthcare is mainly used for imaging of bone structures, tumors, and breast cancer during surgeries, for detecting fractures in bones and teeth, as well as detecting pneumonia. Increasing prevalence of fractures due to osteoporosis, orthopedic disorders, dental problems, and increasing cases of tumor and cancer are expected to boost demand for x-ray equipment in the near future. Rampant advancements in technology and adaptation of advanced medical systems
Sterilization Equipment and Disinfectants Market – Global Industry Insights, T …
Sterilization is process of killing all micro-organisms and pathogens to avoid contamination by means of using physical or chemical treatment. Conversely disinfection is a process to control the growth of micro-organisms and kill a define class of micro-organisms. Disinfection targets narrow spectrum bacteria leaving bacterial spores intact, while sterilization works on broad spectrum micro-organisms. Autoclave uses high pressure and steam to sterilize solid and glass instruments, and liquid mediums in
Generic Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunit …
Generic drugs refers to medication that have the same active ingredient as that of a branded drugs. These drugs also yield the same therapeutic effect and are prescribed in the same dosing, with the same quality, and same the way of consumption and usage. However, the inactive ingredients of generic drugs can differ as compared to their branded counter parts. These drugs are mainly marketed after a patent expiry of

All 5 Releases

More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the